Why is OMDA down?
Down 20% on Nov 6 while the S&P 500 rose 0.3%.
- It reported quarterly revenue of $91.3M after the close on Nov 5.
−2Long-term trend
Down 20% on Nov 6 while the S&P 500 rose 0.3%.
−2Long-term trend
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| The company | Sales up 43% on the year |
| Latest filing | 10-Q, Nov 6 |
After its last 4 reports it closed -1.4% on average, higher 2 of 4 times.
OMDA is #6 of 7 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| 6 |
Expected to report Thu Mar 4, after the close (in 114 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $91.3M, 34% more than a year ago.
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Service | $85.1M | $80.7M | $62.9M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 6)
| Measure | Figure |
|---|---|
| Revenue | $344M to $346M |
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 5, 2026 | -15.6% | -20.4% | not yet |
| Aug 6, 2026 | +6.0% | +21.1% | +24.7% |
| May 7, 2026 | +0.5% | -9.6% | +1.1% |
Sales grew every year from 2023 to 2025, to $260M. It lost money in each of the three years.
RSI 31.4, MACD below signal, below both averages. Not scored.
One trade disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: OMDA is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
“While our market is in an early stage of development, it is evolving rapidly and becoming increasingly competitive.”
OMDA scores 6 today, which Breakaway calls Average. It is #6 of 7 in Services-Health Services by Quality Score, with 2 of 14 chart checks firing. Down 20% on Nov 6 while the S&P 500 rose 0.3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
OMDA scores 6 today, which Breakaway calls Average (6 to 10). That is #6 of 7 in Services-Health Services by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind OMDA's 6.
Expected to report Thu Mar 4, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. OMDA closed higher after 2 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.